5 Best Stocks For Day Trading

4. Zosano Pharma Corporation (NASDAQ:ZSAN)

Number of Hedge Fund Holders: 3   

52-Week Range: $0.32-$3.06

Zosano Pharma Corporation (NASDAQ:ZSAN) is a clinical-stage biotech firm with solid fundamentals. In August, the firm beat market expectations on earnings per share and revenue for the second quarter by $0.02 and $0.01 million respectively. In July, it was also granted a patent for the development of a drug related to the treatment of migraines. 

Earlier in May, the share price of Zosano Pharma Corporation (NASDAQ:ZSAN) had soared 23% on the back of data published in The Journal of Headache and Pain that revealed that Qtrypta, a drug being developed by the firm, was safe and offered relief for migraines when given over the course of a year. 

At the end of the second quarter of 2021, 3 hedge funds in the database of Insider Monkey held stakes worth $1.3 million in Zosano Pharma Corporation (NASDAQ:ZSAN), up from 1 in the preceding quarter worth $199,000.